Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 20 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

10%

2 trials in Phase 3/4

Results Transparency

0%

0 of 8 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

16Total
Not Applicable (13)
P 2 (1)
P 4 (2)

Trial Status

Completed8
Recruiting6
Unknown3
Active Not Recruiting1
Enrolling By Invitation1
Withdrawn1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 8 completed trials

Clinical Trials (20)

Showing 20 of 20 trials
NCT05777031Phase 4RecruitingPrimary

Safety and Efficacy of Collagenase Clostridium Histolyticum After Prior Intralesional PRP for Peyronie's Disease

NCT07317297Not ApplicableRecruitingPrimary

Extracorporeal Shockwave Therapy in the Treatment of Peyronie's Disease

NCT07341529Not ApplicableActive Not RecruitingPrimary

Pilot Study on the Efficacy and Safety of FIBRORESTIL® as an Adjuvant Intralesional Treatment in Patients With Peyronie's Disease Receiving Standard Therapy

NCT06065436Not ApplicableRecruitingPrimary

Concurrent Low Intensity Shockwave Therapy on Collagenase Clostridium Histolyticum for Peyronie's Disease

NCT04512287Phase 2CompletedPrimary

PRP for Treatment of Peyronie's Disease

NCT07010900Not ApplicableRecruitingPrimary

Platelet-Rich Plasma Injections From Cord Blood + Penile Traction vs. Penile Traction Alone in Patients With Peyronie's Disease. Open-label, Single-center Randomized Study

NCT06649539Phase 4RecruitingPrimary

Delayed Dose Collagenase Clostridium Histolyticum (CCH) Protocol for Men With Peyronie's Disease

NCT05871177Not ApplicableCompletedPrimary

Safety and Efficacy of Intralesional HiLow Hyaluronic Acid in the Treatment of Peyronie's Disease (PD)

NCT06621420Enrolling By InvitationPrimary

Peyronie Disease Questionnaire (PDQ): Turkish Validation

NCT05480683Not ApplicableCompletedPrimary

Pelvic CT with Agatston Calcium Score for Peyronie Disease

NCT05768867CompletedPrimary

French Translation and Validation of the PEYronie's Disease QUESTionnaire

NCT04821115Not ApplicableCompletedPrimary

Safety and Efficacy of Low-intensity Shockwave Therapy for Peyronie's Disease

NCT06303661Not ApplicableRecruitingPrimary

Non-ablative Radiofrequency and Low Intensity Shock Wave Therapy in Fibrotic Plaque in Men With Peyronie's Disease

NCT05646602Not ApplicableWithdrawnPrimary

Focused Shock Wave Therapy Outcomes in Peyronie's Disease and Erectile Dysfunction

NCT05316714Not ApplicableUnknownPrimary

Novel Nanofat Regenerative Surgical Technique for Peyronies' Disease Treatment

NCT03774264CompletedPrimary

Treatment Response to Xiaflex for Men With Peyronie's Disease

NCT04370652CompletedPrimary

Medical Treatment of Peyronie's Disease With Collagenase Clostridium Histolyticum

NCT04052217Not ApplicableCompletedPrimary

Does Size Matter: A Single Case Experimental Design of Limiting the Depth of Penetration During Intercourse

NCT03530540Not ApplicableUnknownPrimary

Low-Intensity Extracorporeal Shockwave Therapy and Vacuum Erectile Device as a Treatment for Peyronies Disease.

NCT02414308Not ApplicableUnknown

Management of Peyronie's Disease With Adipose Tissue Stem Cell

Showing all 20 trials

Research Network

Activity Timeline